Hepatitis C virus (HCV) cure rates among those who have received a liver transplant are very good.

Looking at available research on HCV treatment among liver transplantees, Paul Y. Kwo, MD, a gastroenterologist and hepatologist at the Stanford University School of Medicine found cure rates comparable to those seen among individuals who have not received transplants.

Noting 95 percent–plus cure rates and treatment that is well tolerated, Kwo says, “Unlike treatment in the previous interferon era, the risk of rejection and other side effects is markedly lower [with today’s HCV treatments]. Moreover, many of today’s antiviral therapies do not interact in any way with the anti-rejection medicines that would affect the efficacy of the anti-rejection medicines.”